Literature DB >> 27861969

Quality of life of patients with recurrent respiratory papillomatosis.

Michel R M San Giorgi1,2,3, Leena-Maija Aaltonen4, Heikki Rihkanen4, Robin E A Tjon Pian Gi1,2,3, Bernard F A M van der Laan1,2, Josette E H M Hoekstra-Weebers5, Frederik G Dikkers1,2,3.   

Abstract

OBJECTIVES/HYPOTHESIS: Recurrent respiratory papillomatosis (RRP) is a disease with a high disease burden. Few studies have assessed quality of life (QoL) of RRP patients. This study compares QoL of these patients with controls. Associations between QoL and sociodemographic and illness-related factors are examined, as is uptake of psychosocial care and speech therapy. STUDY
DESIGN: Prospective cross-sectional questionnaire research.
METHODS: Ninety-one RRP patients (response = 67%) from two university hospitals in the Netherlands and Finland completed the following patient reported outcome measures: (HADS), 15-dimensional health-related quality-of-life scale (15D), Voice Handicap Index (VHI) and the RAND 36-item health-related quality-of-life survey instrument (RAND-36) assessing health-related QoL and voice handicap, and they provided sociodemographic, illness-related, and allied healthcare use. Descriptive analyses, χ2 tests, t tests, analysis of variance tests, and Pearson correlations were computed to describe the study population and to examine differences between groups.
RESULTS: RRP patients had significantly higher mean scores on depression, health-related QoL (15D) and on voice problems (VHI), and significantly lower mean scores on anxiety than controls. Dutch patients had more pain and a decreased general health perception (RAND-36) than controls. Dutch patients and older patients were more depressed, women were more anxious, older patients had lower health-related QoL, and smoking was significantly associated with voice handicap. Patients who had received psychosocial care had significantly higher HADS-depression mean scores than patients who did not receive psychosocial care.
CONCLUSIONS: Having RRP has significant effect on voice-related QoL and depression, but has no negative effect on anxiety and health-related QoL. Risk factors for decreased functioning are different than previously hypothesized by many authors. Prevention should be aimed at these risk factors. LEVEL OF EVIDENCE: 4. Laryngoscope, 127:1826-1831, 2017.
© 2016 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Recurrent respiratory papillomatosis; psychosocial distress; quality of life; recurrent respiratory papillomatosis

Mesh:

Year:  2016        PMID: 27861969     DOI: 10.1002/lary.26413

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Quality of Life Assessment for Tonsillar Infections and Their Treatment.

Authors:  Berit Hackenberg; Matthias Büttner; Michelle Schöndorf; Sebastian Strieth; Wendelin Schramm; Christoph Matthias; Haralampos Gouveris
Journal:  Medicina (Kaunas)       Date:  2022-04-25       Impact factor: 2.948

2.  A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using Mus musculus Papillomavirus.

Authors:  Renee E King; Andrea Bilger; Josef Rademacher; Ella T Ward-Shaw; Rong Hu; Paul F Lambert; Susan L Thibeault
Journal:  Viruses       Date:  2022-05-08       Impact factor: 5.818

3.  Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement.

Authors:  Douglas R Sidell; Karthik Balakrishnan; Simon R Best; Karen Zur; Julia Buckingham; Alessandro De Alarcon; Fuad M Baroody; Jonathan M Bock; Emily F Boss; Charles M Bower; Paolo Campisi; Sharon F Chen; Jeffrey M Clarke; Kevin D Clarke; Alejandro Cocciaglia; Robin T Cotton; Giselle Cuestas; Kara L Davis; Victor H DeFago; Frederik G Dikkers; Ines Dossans; Walter Florez; Elizabeth Fox; Aaron D Friedman; Nazaneen Grant; Osama Hamdi; Norman D Hogikyan; Kaalan Johnson; Liane B Johnson; Romaine F Johnson; Peggy Kelly; Adam M Klein; Claire M Lawlor; Nicolas Leboulanger; Alejandro G Levy; Derek Lam; Greg R Licameli; Steve Long; David G Lott; Dayse Manrique; James Scott McMurray; Kara D Meister; Anna H Messner; Michael Mohr; Pamela Mudd; Anthony J Mortelliti; Daniel Novakovic; Julian Ongkasuwan; Shazia Peer; Krysztof Piersiala; Jeremy D Prager; Seth M Pransky; Diego Preciado; Tiffany Raynor; Rico N P M Rinkel; Hugo Rodriguez; Verónica P Rodríguez; John Russell; María Laura Scatolini; Patrick Scheffler; David F Smith; Lee P Smith; Marshall E Smith; Richard J H Smith; Abraham Sorom; Amalia Steinberg; John A Stith; Dana Thompson; Jerome W Thompson; Patricio Varela; David R White; Andre M Wineland; Christina J Yang; Carlton J Zdanski; Craig S Derkay
Journal:  Laryngoscope       Date:  2021-01-06       Impact factor: 2.970

Review 4.  An updated review of the epidemiological factors associated with recurrent respiratory papillomatosis.

Authors:  Alexandra Welschmeyer; Gerald S Berke
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-01-28

Review 5.  Recurrent respiratory papillomatosis: A 2020 perspective.

Authors:  Jacob J Benedict; Craig S Derkay
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-03-13

6.  Recurrent respiratory papillomatosis with lower airway involvement in a young woman.

Authors:  Tatiana Mamaeva; Camilla Slot Mehlum; Jesper Rømhild Davidsen
Journal:  Eur Clin Respir J       Date:  2020-03-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.